Global Parecoxib Sodium (CAS 198470-85-8) Market Growth 2022-2028
- LP 4916005
- 91 Pages
- March 2022
- Pharmaceuticals
The United States Parecoxib Sodium (CAS 198470-85-8) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Parecoxib Sodium (CAS 198470-85-8) market, reaching US$ million by the year 2028. As for the Europe Parecoxib Sodium (CAS 198470-85-8) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Parecoxib Sodium (CAS 198470-85-8) players cover Pfizer, Sailong Pharma, Chiarai Tianqing, and Qilu Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Parecoxib Sodium (CAS 198470-85-8) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Original Drug
Generic Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Sailong Pharma
Chiarai Tianqing
Qilu Pharma
Kelun Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Parecoxib Sodium (CAS 198470-85-8) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Parecoxib Sodium (CAS 198470-85-8) by Country/Region, 2017, 2022 & 2028
2.2 Parecoxib Sodium (CAS 198470-85-8) Segment by Type
2.2.1 Original Drug
2.2.2 Generic Drug
2.3 Parecoxib Sodium (CAS 198470-85-8) Sales by Type
2.3.1 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2017-2022)
2.3.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Parecoxib Sodium (CAS 198470-85-8) Sale Price by Type (2017-2022)
2.4 Parecoxib Sodium (CAS 198470-85-8) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Parecoxib Sodium (CAS 198470-85-8) Sales by Application
2.5.1 Global Parecoxib Sodium (CAS 198470-85-8) Sale Market Share by Application (2017-2022)
2.5.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Parecoxib Sodium (CAS 198470-85-8) Sale Price by Application (2017-2022)
3 Global Parecoxib Sodium (CAS 198470-85-8) by Company
3.1 Global Parecoxib Sodium (CAS 198470-85-8) Breakdown Data by Company
3.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Annual Sales by Company (2020-2022)
3.1.2 Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2020-2022)
3.2 Global Parecoxib Sodium (CAS 198470-85-8) Annual Revenue by Company (2020-2022)
3.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Company (2020-2022)
3.2.2 Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Company (2020-2022)
3.3 Global Parecoxib Sodium (CAS 198470-85-8) Sale Price by Company
3.4 Key Manufacturers Parecoxib Sodium (CAS 198470-85-8) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Parecoxib Sodium (CAS 198470-85-8) Product Location Distribution
3.4.2 Players Parecoxib Sodium (CAS 198470-85-8) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Parecoxib Sodium (CAS 198470-85-8) by Geographic Region
4.1 World Historic Parecoxib Sodium (CAS 198470-85-8) Market Size by Geographic Region (2017-2022)
4.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Parecoxib Sodium (CAS 198470-85-8) Annual Revenue by Geographic Region
4.2 World Historic Parecoxib Sodium (CAS 198470-85-8) Market Size by Country/Region (2017-2022)
4.2.1 Global Parecoxib Sodium (CAS 198470-85-8) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Parecoxib Sodium (CAS 198470-85-8) Annual Revenue by Country/Region
4.3 Americas Parecoxib Sodium (CAS 198470-85-8) Sales Growth
4.4 APAC Parecoxib Sodium (CAS 198470-85-8) Sales Growth
4.5 Europe Parecoxib Sodium (CAS 198470-85-8) Sales Growth
4.6 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Growth
5 Americas
5.1 Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Country
5.1.1 Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2017-2022)
5.1.2 Americas Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2017-2022)
5.2 Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Type
5.3 Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Region
6.1.1 APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2017-2022)
6.1.2 APAC Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2017-2022)
6.2 APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Type
6.3 APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Parecoxib Sodium (CAS 198470-85-8) by Country
7.1.1 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2017-2022)
7.1.2 Europe Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2017-2022)
7.2 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Type
7.3 Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) by Country
8.1.1 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2017-2022)
8.2 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Type
8.3 Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Parecoxib Sodium (CAS 198470-85-8)
10.3 Manufacturing Process Analysis of Parecoxib Sodium (CAS 198470-85-8)
10.4 Industry Chain Structure of Parecoxib Sodium (CAS 198470-85-8)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Parecoxib Sodium (CAS 198470-85-8) Distributors
11.3 Parecoxib Sodium (CAS 198470-85-8) Customer
12 World Forecast Review for Parecoxib Sodium (CAS 198470-85-8) by Geographic Region
12.1 Global Parecoxib Sodium (CAS 198470-85-8) Market Size Forecast by Region
12.1.1 Global Parecoxib Sodium (CAS 198470-85-8) Forecast by Region (2023-2028)
12.1.2 Global Parecoxib Sodium (CAS 198470-85-8) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Parecoxib Sodium (CAS 198470-85-8) Forecast by Type
12.7 Global Parecoxib Sodium (CAS 198470-85-8) Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Parecoxib Sodium (CAS 198470-85-8) Product Offered
13.1.3 Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sailong Pharma
13.2.1 Sailong Pharma Company Information
13.2.2 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Product Offered
13.2.3 Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sailong Pharma Main Business Overview
13.2.5 Sailong Pharma Latest Developments
13.3 Chiarai Tianqing
13.3.1 Chiarai Tianqing Company Information
13.3.2 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Product Offered
13.3.3 Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Chiarai Tianqing Main Business Overview
13.3.5 Chiarai Tianqing Latest Developments
13.4 Qilu Pharma
13.4.1 Qilu Pharma Company Information
13.4.2 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Product Offered
13.4.3 Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Qilu Pharma Main Business Overview
13.4.5 Qilu Pharma Latest Developments
13.5 Kelun Pharma
13.5.1 Kelun Pharma Company Information
13.5.2 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Product Offered
13.5.3 Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Kelun Pharma Main Business Overview
13.5.5 Kelun Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Parecoxib Sodium (CAS 198470-85-8) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Parecoxib Sodium (CAS 198470-85-8) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Original Drug
Table 4. Major Players of Generic Drug
Table 5. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2017-2022) & (Kg)
Table 6. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2017-2022)
Table 7. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Type (2017-2022)
Table 9. Global Parecoxib Sodium (CAS 198470-85-8) Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2017-2022) & (Kg)
Table 11. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2017-2022)
Table 12. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Application (2017-2022)
Table 13. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Application (2017-2022)
Table 14. Global Parecoxib Sodium (CAS 198470-85-8) Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Company (2020-2022) & (Kg)
Table 16. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Company (2020-2022)
Table 17. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Company (2020-2022)
Table 19. Global Parecoxib Sodium (CAS 198470-85-8) Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Parecoxib Sodium (CAS 198470-85-8) Producing Area Distribution and Sales Area
Table 21. Players Parecoxib Sodium (CAS 198470-85-8) Products Offered
Table 22. Parecoxib Sodium (CAS 198470-85-8) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Geographic Region (2017-2022) & (Kg)
Table 26. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Parecoxib Sodium (CAS 198470-85-8) Sales by Country/Region (2017-2022) & (Kg)
Table 30. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Parecoxib Sodium (CAS 198470-85-8) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2017-2022) & (Kg)
Table 34. Americas Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2017-2022)
Table 35. Americas Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2017-2022)
Table 37. Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2017-2022) & (Kg)
Table 38. Americas Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2017-2022)
Table 39. Americas Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2017-2022) & (Kg)
Table 40. Americas Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2017-2022)
Table 41. APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2017-2022) & (Kg)
Table 42. APAC Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2017-2022)
Table 43. APAC Parecoxib Sodium (CAS 198470-85-8) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Region (2017-2022)
Table 45. APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2017-2022) & (Kg)
Table 46. APAC Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2017-2022)
Table 47. APAC Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2017-2022) & (Kg)
Table 48. APAC Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2017-2022)
Table 49. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2017-2022) & (Kg)
Table 50. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2017-2022)
Table 51. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2017-2022)
Table 53. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2017-2022) & (Kg)
Table 54. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2017-2022)
Table 55. Europe Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2017-2022) & (Kg)
Table 56. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Country (2017-2022) & (Kg)
Table 58. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Type (2017-2022) & (Kg)
Table 62. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales by Application (2017-2022) & (Kg)
Table 64. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Parecoxib Sodium (CAS 198470-85-8)
Table 66. Key Market Challenges & Risks of Parecoxib Sodium (CAS 198470-85-8)
Table 67. Key Industry Trends of Parecoxib Sodium (CAS 198470-85-8)
Table 68. Parecoxib Sodium (CAS 198470-85-8) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Parecoxib Sodium (CAS 198470-85-8) Distributors List
Table 71. Parecoxib Sodium (CAS 198470-85-8) Customer List
Table 72. Global Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Region (2023-2028) & (Kg)
Table 73. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Forecast by Region
Table 74. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Country (2023-2028) & (Kg)
Table 77. Americas Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Region (2023-2028) & (Kg)
Table 79. APAC Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Country (2023-2028) & (Kg)
Table 81. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Country (2023-2028) & (Kg)
Table 83. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Type (2023-2028) & (Kg)
Table 85. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Parecoxib Sodium (CAS 198470-85-8) Sales Forecast by Application (2023-2028) & (Kg)
Table 89. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Basic Information, Parecoxib Sodium (CAS 198470-85-8) Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Parecoxib Sodium (CAS 198470-85-8) Product Offered
Table 94. Pfizer Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Sailong Pharma Basic Information, Parecoxib Sodium (CAS 198470-85-8) Manufacturing Base, Sales Area and Its Competitors
Table 98. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Product Offered
Table 99. Sailong Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. Sailong Pharma Main Business
Table 101. Sailong Pharma Latest Developments
Table 102. Chiarai Tianqing Basic Information, Parecoxib Sodium (CAS 198470-85-8) Manufacturing Base, Sales Area and Its Competitors
Table 103. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Product Offered
Table 104. Chiarai Tianqing Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Chiarai Tianqing Main Business
Table 106. Chiarai Tianqing Latest Developments
Table 107. Qilu Pharma Basic Information, Parecoxib Sodium (CAS 198470-85-8) Manufacturing Base, Sales Area and Its Competitors
Table 108. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Product Offered
Table 109. Qilu Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Qilu Pharma Main Business
Table 111. Qilu Pharma Latest Developments
Table 112. Kelun Pharma Basic Information, Parecoxib Sodium (CAS 198470-85-8) Manufacturing Base, Sales Area and Its Competitors
Table 113. Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Product Offered
Table 114. Kelun Pharma Parecoxib Sodium (CAS 198470-85-8) Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Kelun Pharma Main Business
Table 116. Kelun Pharma Latest Developments
List of Figures
Figure 1. Picture of Parecoxib Sodium (CAS 198470-85-8)
Figure 2. Parecoxib Sodium (CAS 198470-85-8) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Parecoxib Sodium (CAS 198470-85-8) Sales Growth Rate 2017-2028 (Kg)
Figure 7. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Parecoxib Sodium (CAS 198470-85-8) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Original Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Type in 2021
Figure 12. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Type (2017-2022)
Figure 13. Parecoxib Sodium (CAS 198470-85-8) Consumed in Hospital Pharmacies
Figure 14. Global Parecoxib Sodium (CAS 198470-85-8) Market: Hospital Pharmacies (2017-2022) & (Kg)
Figure 15. Parecoxib Sodium (CAS 198470-85-8) Consumed in Retail Pharmacies
Figure 16. Global Parecoxib Sodium (CAS 198470-85-8) Market: Retail Pharmacies (2017-2022) & (Kg)
Figure 17. Parecoxib Sodium (CAS 198470-85-8) Consumed in Online Pharmacies
Figure 18. Global Parecoxib Sodium (CAS 198470-85-8) Market: Online Pharmacies (2017-2022) & (Kg)
Figure 19. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Application (2017-2022)
Figure 20. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Application in 2021
Figure 21. Parecoxib Sodium (CAS 198470-85-8) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Company in 2021
Figure 23. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region (2017-2022)
Figure 26. Global Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Parecoxib Sodium (CAS 198470-85-8) Sales 2017-2022 (Kg)
Figure 28. Americas Parecoxib Sodium (CAS 198470-85-8) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Parecoxib Sodium (CAS 198470-85-8) Sales 2017-2022 (Kg)
Figure 30. APAC Parecoxib Sodium (CAS 198470-85-8) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Parecoxib Sodium (CAS 198470-85-8) Sales 2017-2022 (Kg)
Figure 32. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales 2017-2022 (Kg)
Figure 34. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2021
Figure 36. Americas Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2021
Figure 37. United States Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Region in 2021
Figure 42. APAC Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Regions in 2021
Figure 43. China Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2021
Figure 50. Europe Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2021
Figure 51. Germany Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Market Share by Country in 2021
Figure 58. Egypt Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Parecoxib Sodium (CAS 198470-85-8) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Parecoxib Sodium (CAS 198470-85-8) in 2021
Figure 64. Manufacturing Process Analysis of Parecoxib Sodium (CAS 198470-85-8)
Figure 65. Industry Chain Structure of Parecoxib Sodium (CAS 198470-85-8)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
